Summary of the 59th Annual Congress of the European Association for the Study of Diabetes
Authors:
Peter Novodvorský 1,2,3
Authors‘ workplace:
metabolické centrum s. r. o., Trenčín
1; Centrum diabetologie IKEM, Praha
2; Department of Oncology and Metabolism, Medical School, University of Sheffield, United Kingdom
3
Published in:
Diab Obez 2023; 23(46): 128-129
Category:
Sources
- Lee TT, Collett C, Bergford S et al. Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes. N Engl J Med 2023. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa2303911>.
- Rosenstock J, Bain SC, Gowda A et al. [ONWARDS 1 Trial Investigators]. Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin. N Engl J Med 2023; 389(4): 297–308. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa2303208>.
- Lingvay I, Asong M, Desouza C et al. Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial. JAMA 2023; 330(3): 228–237. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2023.11313>.
Labels
Diabetology ObesitologyArticle was published in
Diabetes a obezita
2023 Issue 46
Most read in this issue
- Prevalence of obesity and type 2 diabetes mellitus
- Prevalence and mortality of patients with type 2 diabetes mellitus in 2010–2015 and mortality during the COVID pandemic (April 2020–March 2021)
- Screening for diabetic retinopathy in diabetic outpatient clinics using arteficial intelligence: a pilot project of the Slovak Diabetes Society
- Cardio-renal and metabolic benefits of empagliflozin: additional indication and change in indication restrictions